Proinflammatory Cytokines and Treatment of Disease
- 1 September 1998
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 856 (1) , 243-251
- https://doi.org/10.1111/j.1749-6632.1998.tb08331.x
Abstract
Bacterial infections in the immunocompromised host cause considerable mortality, and even recently developed antimicrobial strategies often fail to cure these infections, especially in granulocytopenic patients. Cytokines and hematopoietic growth factors have been shown to stimulate host defense mechanisms in vitro and in vivo. The possible role of the proinflammatory cytokines interleukin (IL)-1, tumor necrosis factor-α, IL-6, and IL-8 as modulators of host resistance to bacterial infections is discussed. Interleukin-1 has been effective in various animal models of potentially lethal bacterial infection, even during severe granulocytopenia. The protective mechanism of IL-1 may be mediated by downregulation of cytokine receptors and cytokine production and induction of acute phase proteins. Moreover, in subacute and chronic infections IL-1 interferes with microbial outgrowth via mechanisms that have only been partly elucidated.Keywords
This publication has 58 references indexed in Scilit:
- The effect of interleukin 1α on acetaminophen-induced hepatotoxicityCytokine, 1993
- Recent Advances in Cytokine Therapy in LeprosyThe Journal of Infectious Diseases, 1993
- Tumor Necrosis Factor-Alpha: Central Regulatory Cytokine in the Induction of Macrophage Antimicrobial ActivitiesPathobiology, 1991
- Low dosages of interleukin 1 protect mice against lethal cerebral malaria.The Journal of Experimental Medicine, 1990
- Recombinant γ-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients†Hepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growthJournal of Molecular Medicine, 1989
- Enhanced antibacterial resistance in neutropenic mice treated with human recombinant interleukin-1 betaInflammation Research, 1988
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Nonspecific Resistance to InfectionsAnnual Review of Microbiology, 1959